Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700009369

Trial Profile

Clinical Trials Insight: 700009369

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 19 Jan 2008

At a glance

  • Drugs Carmustine polifeprosan 20 wafer (Primary)
  • Indications Glioma
  • Focus Therapeutic Use
  • Sponsors MGI Pharma
  • Most Recent Events

    • 19 Jan 2008 Results will be published in the Journal of Neurosurgery in February 2008.
    • 28 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top